相关实验视频
Updated: Sep 19, 2025

12:21
Feeder-free Derivation of Melanocytes from Human Pluripotent Stem Cells
Published on: March 3, 2016
10.5K
SOX10,MITF和microRNAs:解读它们在调节黑色素瘤可塑性的相互作用
Xin Lai1,2,3, Chunyan Luan3, Zhesi Zhang1
1Biomedicine Unit, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
International journal of cancer
|June 3, 2025
概括
对SOX10转录因子的失调是黑色素瘤的关键. 微RNAs (miRNAs) 与SOX10相互作用,形成控制黑色素瘤细胞可塑性和治疗反应的网络.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 网络生物学 网络生物学
背景情况:
- SOX10转录因子失调驱动黑色素瘤的发展和进展.
- 微RNAs (miRNAs) 在转录后调节基因表达,影响转录因子活性.
- SOX10和miRNAs之间的相互作用形成了调节性网络动机,这对黑色素瘤生物学至关重要.
研究的目的:
- 审查和讨论黑色素瘤中SOX10和miRNA之间的相互作用.
- 调查基因调节相互作用和涉及黑色素瘤中SOX10,MITF和miRNA的网络动机.
- 通过控制理论来解释这些动态和黑色素瘤细胞表型可塑性之间的联系.
主要方法:
- 在黑色素瘤中SOX10-miRNA相互作用的文献综述和讨论.
- 研究黑色素瘤中的基因调控网络,确定关键动机.
- 在已识别的图案中分析组件表达水平.
- 控制理论的应用来解释表型可塑性.
主要成果:
- SOX10和miRNA的相互作用形成影响黑色素瘤的网络动机 (Feedforward/Feedback循环).
- 这些动机驱动基因表达的非线性动态,影响瘤增殖,转移和治疗反应.
- 确定了涉及SOX10,MITF和miRNA的关键网络动机,并分析了表达水平.
结论:
- 以数据为导向的网络生物学方法对于理解黑色素瘤调节机制至关重要.
- 在黑色素瘤中通过miRNA阐明SOX10和MITF调节,可以了解表型可塑性.
- 这些发现可能有助于开发基于miRNA的新黑色素瘤治疗方法.
相关概念视频
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
Pleiotropy
41.2K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
41.2K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Somatic to iPS Cell Reprogramming
2.3K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.3K
Adaptive Mechanisms in Cancer Cells
6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K

